JUPITER, Fla. - SQ Innovation Inc. has received U.S. Food and Drug Administration approval for Lasix ONYU, a novel drug-device combination that allows heart failure patients to receive furosemide ...

Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors Lasix ONYU is the 17 th Captisol-enabled™ approved product JUPITER, Fla.

BURLINGTON, Mass., Oct. 8, 2025 /PRNewswire/ -- SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ® ONYU (furosemide ...

Hyponatremia, a dangerous condition of low blood sodium from excessive water intake, causes cell swelling and can severely impact the brain. Recognizing symptoms like headache or confusion is crucial, ...

With a buyout of scPharmaceuticals worth up to $360 million, MannKind is looking to dive into the large and growing field of cardiometabolic treatments. Endocrine and orphan lung disease-focused ...

Hyponatremia, or low blood sodium concentration, is typically viewed as a symptomless condition-until recently. A research team led by Professor Yoshihisa Sugimura, including Dr. Haruki Fujisawa, ...

It’s a well-known fact that the human body is more than 60% fluid. In addition to water, your bodily fluids contain vitamins, minerals, and other nutrients that keep the body functioning well. Sodium ...

Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure. Last year, the drug developer noted that FDA feedback from a 2023 Type D ...

Hyperglycemia refers to high blood glucose levels, while hyponatremia refers to low blood sodium levels. While they are different conditions, some people with hyperglycemia might also have ...

Please provide your email address to receive an email when new articles are posted on . Patients referred within the first day of admission had a median 8.41-day hospital stay. Patients referred after ...